𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells

✍ Scribed by Nagathihalli S. Nagaraj; Nadarajah Vigneswaran; Wolfgang Zacharias


Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
623 KB
Volume
132
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pretreatment of docetaxel enhances TRAIL
✍ Jinsang Yoo; Sung-Soo Park; Yong J. Lee πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 367 KB πŸ‘ 1 views

## Abstract Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity. TRAIL is known to induce apoptosis in cancer cells but spare most normal cells. In this study, we examined whether treatment of docetaxel (DTX) can e

Fem1b, a proapoptotic protein, mediates
✍ M. Cecilia Subauste; Owen J. Sansom; Nehal Porecha; Natacha Raich; Liqin Du; Jos πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 296 KB

## Abstract In the treatment of colon cancer, the development of resistance to apoptosis is a major factor in resistance to therapy. New molecular approaches to overcome apoptosis resistance, such as selectively upregulating proapoptotic proteins, are needed in colon cancer therapy. In a mouse mode

Progesterone induces Apoptosis in TRAIL-
✍ Viqar Syed; Kasturi Mukherjee; Sonia Godoy-Tundidor; Shuk-Mei Ho πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 356 KB πŸ‘ 1 views

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) holds great potential as an anticancer drug, since it induces selective cell death in cancer cells but not in normal ones. However, cancer cells often acquire resistance to TRAIL, which hinders its clinical efficacy. We previously demon